Newsroom

Graphic of Cryo-electron microscope reconstruction of the antigen binding region

News

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared. Researchers at the German Center for Infection Research (DZIF), the University Hospital Cologne, the Helmholtz Centre for Infection Research in Braunschweig and the University Medical Center Hamburg-Eppendorf have now discovered antibodies that could lead to a highly potent treatment option of acute and chronic infections with P. aeruginosa. The study was published in the prestigious scientific journal Cell.

02.11.2023

HZI Campus

Crystal structure of LasB in complex with a ligand

News

Researchers from the Department of Drug Design and Optimisation have developed molecules that can drastically reduce the pathogenic effects of the hospital germ Pseudomonas aeruginosa. In this interview, the authors Dr. Jörg Haupenthal and Dr. Andreas Kany tell us why P. aeruginosa is such a big problem, provide insights into their novel treatment strategy and explain which steps are still necessary before clinical use. Their work was published in the journal ACS Central Science.

30.10.2023

HIPS

HZI Campus

News

The Academy of Sciences in Hamburg awards Prof Fabian Leendertz, Director of the Helmholtz Institute for One Health (HIOH), the Hamburg Science Award 2023 for his fundamental work in the field of zoonotic infectious diseases using the One Health concept. Leendertz's research contributes significantly to a better understanding of the mechanisms of disease development and transmission between humans, animals and the environment. The One Health surveillance studies conducted by the Helmholtz Institute for One Health, a site of the Helmholtz Centre for Infection Research (HZI), in sub-Saharan Africa play a crucial role in the prevention of epidemics and pandemics.

13.10.2023

HIOH

News

The Alliance of Science Organisations in Germany expresses its deepest condolences for the victims of the terrorist attacks on Israel. In particular, our sympathy is with our friends and colleagues in the Israeli scientific community. Israel has been and will always be a prime partner for the German research and innovation community.

12.10.2023

HZI Campus

New findings on SARS-CoV-2: Jun Prof Mathias Munschauer with PhD student Sabina Ganskih in the lab.

News

How SARS-CoV-2 initiates its replication process during infection is not yet fully understood. Researchers from the Helmholtz Institute Würzburg have now shown for the first time in the journal Cell that it is the human protein SND1 which works together with the viral protein NSP9 to stimulate the virus’s genetic replication program in infected cells. The scientists were surprised to find that NSP9 acts as the first building block in the production of new viral genetic material. The findings are significant for further basic research, but they could also lead to new avenues for the treatment of COVID-19 and other infectious diseases caused by coronaviruses.

04.10.2023

HIRI

The Microbelix team at the award ceremony at the Museum für Naturkunde in Berlin ©WID/Gesine Born

News

The cooperation project MICROBELIX was jointly launched in spring 2023 by researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the Naturlandstiftung Saar (NLS). Together, both institutions set out to compete in the citizen science contest Auf die Plätze! Citizen Science in deiner Stadt. After a public voting phase and the evaluation by a jury of experts, the MICROBELIX team could claim one of the three winning places and a 50,000 € prize. The award ceremony took place on September 28, 2023 at the Museum für Naturkunde in Berlin.

28.09.2023

HIPS

Back to the first page
...
33
34
35
36
...
150

HZI in the media

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

19.12.2025

healthcare-in-europe.com

Biosyntheseweg aufzuklären. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit ...

18.12.2025

Bionity.COM

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Korte from the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI).

The research was carried out as

12.12.2025

The Hindu

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025

Bionity.COM

Einrichtungen des regionalen Forschungsökosystems – darunter das Helmholtz-Zentrum für Infektionsforschung (HZI), das Deutsche Zentrum für

12.12.2025

EUROPE SAYS

Korte of the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI). The findings emerged from the

12.12.2025

The New Indian Express

Universität Würzburg. Seit 2018: Postdoc am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Entwicklung Bayes’scher ...

12.12.2025

BIOspektrum

Center Borstel - Leibniz Lung Center, the Helmholtz Institute for Pharmaceutical Research Saarland and other scientific institutions in

11.12.2025

Technology Networks

von Humboldt professor, head of department at the Helmholtz Centre for Infection Research, Braunschweig and full professor at the Hannover

10.12.2025

European Research Council

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.